Reduced GLP-1R Expression in Gastric Glands of Patients With Type 2 Diabetes Mellitus-Reference-Cited by-同舟云学术

Reduced GLP-1R Expression in Gastric Glands of Patients With Type 2 Diabetes Mellitus

Author:

Broide E.¹²,Bloch O.³²,Ben-Yehudah G.¹²,Cantrell D.⁴²,Shirin H.¹²,Rapoport M. J.³⁴²

Affiliation:

1. Institute of Gastroenterology (E.B., G.B.-Y., H.S.), Zerifin 70300, Israel

2. Sackler Faculty of Medicine Tel Aviv University (E.B., O.B., G.B.-Y., D.C., H.S., M.J.R., Tel Aviv 69978, Israel

3. Diabetes and Immunology Research Laboratory (O.B, M.J.R.), Zerifin 70300, Israel

4. Department of Internal Medicine “C” (D.C., M.J.R), Assaf Harofeh Medical Center, Zerifin 70300, Israel

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

Reference20 articles.

1. On the role of the incretin hormones GIP and GLP-1 in the pathogenesis of type 2 diabetes mellitus;Vilsbøll;Dan Med Bull,2004

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

5. Glucagon‐Like Peptide‐1 Receptor Activators;Burger's Medicinal Chemistry and Drug Discovery;2021-04-28